|
End-of-day quote
Taipei Exchange
04/09/2026
|
5-day change | 1st Jan Change | ||
| 91.90 TWD | +1.32% |
|
-3.57% | -69.77% |
| Market Cap | 6.14B 194M 167M 157M 144M 268M 18.32B 269M 1.86B 720M 9.4B 729M 713M 30.28B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 3.85B 122M 105M 98.42M 89.91M 168M 11.48B 169M 1.16B 451M 5.89B 456M 447M 18.97B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
57.17% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | +1.32% | ||
| 1 week | -3.57% | ||
| Current month | -2.96% | ||
| 1 month | -7.08% | ||
| 3 months | -23.10% | ||
| 6 months | -52.14% | ||
| Current year | -69.77% |
| 1 week | 90.6 |  | 94.6 |
| 1 month | 90.6 | | 105.5 |
| Current year | 90.6 | | 313 |
| 1 year | 90.6 | | 317 |
| 3 years | 90.6 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 22/09/2016 |
Vivian Kang
DFI | Director of Finance/CFO | - | 15/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 22/09/2016 |
Yung Shun Wen
BRD | Director/Board Member | - | 22/09/2016 |
Cheng Yu Fang
BRD | Director/Board Member | - | 06/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.32% | -3.57% | -59.16% | -32.43% | 194M | |
| -1.32% | +1.33% | +77.46% | +41.17% | 371B | |
| -0.90% | -3.14% | +24.01% | -18.97% | 68.64B | |
| -0.51% | +4.59% | +47.06% | +168.63% | 12.51B | |
| -0.56% | -9.06% | -8.11% | -8.78% | 8.06B | |
| +0.23% | -1.59% | -20.70% | +6.13% | 5.04B | |
| 0.00% | -4.12% | -31.60% | +20.55% | 4.51B | |
| -0.35% | -3.11% | -33.77% | +1.20% | 3.07B | |
| -1.00% | -0.46% | -5.37% | +37.45% | 2.53B | |
| -0.50% | -3.98% | -24.35% | -16.61% | 2B | |
| Average | -0.35% | -1.87% | -3.45% | +19.83% | 47.74B | |
| Weighted average by Cap. | -1.17% | +0.47% | +63.84% | +33.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 184K 158K 149K 136K 254K 17.36M 255K 1.76M 683K 8.91M 690K 675K 28.69M | 2.75M 87.02K 74.88K 70.45K 64.36K 120K 8.22M 121K 832K 323K 4.22M 327K 320K 13.58M |
| Net income | 18.17M 574K 494K 465K 425K 795K 54.22M 797K 5.49M 2.13M 27.82M 2.16M 2.11M 89.62M | -79.68M -2.52M -2.17M -2.04M -1.86M -3.48M -238M -3.49M -24.1M -9.35M -122M -9.46M -9.25M -393M |
| Net Debt | -2.43B -76.82M -66.1M -62.19M -56.81M -106M -7.25B -107M -735M -285M -3.72B -288M -282M -11.99B | -2.29B -72.47M -62.36M -58.67M -53.6M -100M -6.84B -101M -693M -269M -3.51B -272M -266M -11.31B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | NT$91.90 | +1.32% | 27,749 |
| 03/09/26 | NT$90.70 | -0.55% | 36,862 |
| 02/09/26 | NT$91.20 | -1.08% | 46,739 |
| 01/09/26 | NT$92.20 | -2.64% | 92,741 |
| 31/08/26 | NT$94.70 | -0.63% | 65,933 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Select your edition
All financial news and data tailored to specific country editions
